Shield Therapeutics Appoints Santosh Shanbhag as New CFO, Effective January 16, 2024
with Akili Inc. as CFO.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 GBX | +29.63% | +22.81% | -73.88% |
Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
Apr. 30 | Transcript : Shield Therapeutics plc, 2023 Earnings Call, Apr 30, 2024 |
1st Jan change | Capi. | |
---|---|---|
-73.88% | 13.22M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |